Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes

Yen Hua Huang, Tzong Huei Lee, Kuei Jung Chan, Feng Lin Hsu, Yu Chih Wu, Mei Hsien Lee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Melanin is the pigment responsible for skin color. Melanin synthesis occurs with the participation of the tyrosinase (TYR) family of proteins including TYR, tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein 2 (TRP2/DCT). Objective: The effect of a newly isolated natural compound that inhibits hyperpigmentation on the regulation of the TYR family of proteins was examined. Methods: The natural compound, anemonin, was isolated from Clematis crassifolia Benth and was used to inhibit cellular TYR activity; it was found to have a low cytotoxicity (cell viability > 80%) in human melanocytes. Results: In human melanocytes, anemonin showed both time- and dose-dependent inhibition (IC50 43.5 μM) of TYR. Western blot analysis and immunocytochemical staining revealed that expression of TYR, TRP1, and TRP2 was decreased in anemonin-treated melanocytes. Additionally, reverse transcription and quantitative real-time polymerase chain reaction analyses revealed that expression of mRNAs for MITF, TYR, TYRP1, and TYRP2 was also suppressed by anemonin. Conclusion: The natural compound, anemonin, an active compound of C. crassifolia, inhibits pigmentation synthesis in human melanocytes. Anemonin inhibits melanin synthesis by inhibiting the transcription of the genes encoding MITF, TYR, TRP1, and TRP2. This natural compound may be a candidate for cosmetic use.

Original languageEnglish
Pages (from-to)115-123
Number of pages9
JournalJournal of Dermatological Science
Volume49
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Monophenol Monooxygenase
Melanocytes
Messenger RNA
Melanins
Proteins
Transcription
Clematis
Skin Pigmentation
Hyperpigmentation
Gene encoding
Cosmetics
anemonin
Polymerase chain reaction
Pigmentation
Cytotoxicity
Pigments
Inhibitory Concentration 50
Reverse Transcription
Real-Time Polymerase Chain Reaction
Cell Survival

Keywords

  • Anemonin
  • Melanocytes
  • Quantitative real-time polymerase chain
  • Tyrosinase
  • Tyrosinase-related proteins

ASJC Scopus subject areas

  • Dermatology

Cite this

Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes. / Huang, Yen Hua; Lee, Tzong Huei; Chan, Kuei Jung; Hsu, Feng Lin; Wu, Yu Chih; Lee, Mei Hsien.

In: Journal of Dermatological Science, Vol. 49, No. 2, 02.2008, p. 115-123.

Research output: Contribution to journalArticle

@article{7cbe68e20288448ebf8ffbd3a362e578,
title = "Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes",
abstract = "Background: Melanin is the pigment responsible for skin color. Melanin synthesis occurs with the participation of the tyrosinase (TYR) family of proteins including TYR, tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein 2 (TRP2/DCT). Objective: The effect of a newly isolated natural compound that inhibits hyperpigmentation on the regulation of the TYR family of proteins was examined. Methods: The natural compound, anemonin, was isolated from Clematis crassifolia Benth and was used to inhibit cellular TYR activity; it was found to have a low cytotoxicity (cell viability > 80{\%}) in human melanocytes. Results: In human melanocytes, anemonin showed both time- and dose-dependent inhibition (IC50 43.5 μM) of TYR. Western blot analysis and immunocytochemical staining revealed that expression of TYR, TRP1, and TRP2 was decreased in anemonin-treated melanocytes. Additionally, reverse transcription and quantitative real-time polymerase chain reaction analyses revealed that expression of mRNAs for MITF, TYR, TYRP1, and TYRP2 was also suppressed by anemonin. Conclusion: The natural compound, anemonin, an active compound of C. crassifolia, inhibits pigmentation synthesis in human melanocytes. Anemonin inhibits melanin synthesis by inhibiting the transcription of the genes encoding MITF, TYR, TRP1, and TRP2. This natural compound may be a candidate for cosmetic use.",
keywords = "Anemonin, Melanocytes, Quantitative real-time polymerase chain, Tyrosinase, Tyrosinase-related proteins",
author = "Huang, {Yen Hua} and Lee, {Tzong Huei} and Chan, {Kuei Jung} and Hsu, {Feng Lin} and Wu, {Yu Chih} and Lee, {Mei Hsien}",
year = "2008",
month = "2",
doi = "10.1016/j.jdermsci.2007.07.008",
language = "English",
volume = "49",
pages = "115--123",
journal = "Journal of Dermatological Science",
issn = "0923-1811",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes

AU - Huang, Yen Hua

AU - Lee, Tzong Huei

AU - Chan, Kuei Jung

AU - Hsu, Feng Lin

AU - Wu, Yu Chih

AU - Lee, Mei Hsien

PY - 2008/2

Y1 - 2008/2

N2 - Background: Melanin is the pigment responsible for skin color. Melanin synthesis occurs with the participation of the tyrosinase (TYR) family of proteins including TYR, tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein 2 (TRP2/DCT). Objective: The effect of a newly isolated natural compound that inhibits hyperpigmentation on the regulation of the TYR family of proteins was examined. Methods: The natural compound, anemonin, was isolated from Clematis crassifolia Benth and was used to inhibit cellular TYR activity; it was found to have a low cytotoxicity (cell viability > 80%) in human melanocytes. Results: In human melanocytes, anemonin showed both time- and dose-dependent inhibition (IC50 43.5 μM) of TYR. Western blot analysis and immunocytochemical staining revealed that expression of TYR, TRP1, and TRP2 was decreased in anemonin-treated melanocytes. Additionally, reverse transcription and quantitative real-time polymerase chain reaction analyses revealed that expression of mRNAs for MITF, TYR, TYRP1, and TYRP2 was also suppressed by anemonin. Conclusion: The natural compound, anemonin, an active compound of C. crassifolia, inhibits pigmentation synthesis in human melanocytes. Anemonin inhibits melanin synthesis by inhibiting the transcription of the genes encoding MITF, TYR, TRP1, and TRP2. This natural compound may be a candidate for cosmetic use.

AB - Background: Melanin is the pigment responsible for skin color. Melanin synthesis occurs with the participation of the tyrosinase (TYR) family of proteins including TYR, tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein 2 (TRP2/DCT). Objective: The effect of a newly isolated natural compound that inhibits hyperpigmentation on the regulation of the TYR family of proteins was examined. Methods: The natural compound, anemonin, was isolated from Clematis crassifolia Benth and was used to inhibit cellular TYR activity; it was found to have a low cytotoxicity (cell viability > 80%) in human melanocytes. Results: In human melanocytes, anemonin showed both time- and dose-dependent inhibition (IC50 43.5 μM) of TYR. Western blot analysis and immunocytochemical staining revealed that expression of TYR, TRP1, and TRP2 was decreased in anemonin-treated melanocytes. Additionally, reverse transcription and quantitative real-time polymerase chain reaction analyses revealed that expression of mRNAs for MITF, TYR, TYRP1, and TYRP2 was also suppressed by anemonin. Conclusion: The natural compound, anemonin, an active compound of C. crassifolia, inhibits pigmentation synthesis in human melanocytes. Anemonin inhibits melanin synthesis by inhibiting the transcription of the genes encoding MITF, TYR, TRP1, and TRP2. This natural compound may be a candidate for cosmetic use.

KW - Anemonin

KW - Melanocytes

KW - Quantitative real-time polymerase chain

KW - Tyrosinase

KW - Tyrosinase-related proteins

UR - http://www.scopus.com/inward/record.url?scp=37349008953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349008953&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2007.07.008

DO - 10.1016/j.jdermsci.2007.07.008

M3 - Article

C2 - 17766092

AN - SCOPUS:37349008953

VL - 49

SP - 115

EP - 123

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

SN - 0923-1811

IS - 2

ER -